Rhabdomyosarcoma of the infratemporal fossa.
The outlook for children suffering from this most common soft tissue sarcoma is vastly better today than it was 15 years ago, when fewer than 20 percent of its victims survived. Continuing advances in treatment should increase survival rates even more in the future.